These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Asthma update: Part II. Medical management. Mintz M Am Fam Physician; 2004 Sep; 70(6):1061-6. PubMed ID: 15456115 [TBL] [Abstract][Full Text] [Related]
45. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. Hancox RJ; Taylor DR BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672 [TBL] [Abstract][Full Text] [Related]
46. American Academy of Pediatrics. Section on Allergy and Immunology. Management of asthma. Pediatrics; 1981 Dec; 68(6):874-9. PubMed ID: 6119674 [TBL] [Abstract][Full Text] [Related]
47. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. Sharpe M; Jarvis B Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026 [TBL] [Abstract][Full Text] [Related]
50. Comparison of two different dose regimens of nedocromil sodium with placebo in the management of childhood asthma. Sekerel BE; SaraƧlar Y; Etikan I; Kalayci O J Investig Allergol Clin Immunol; 1999; 9(5):293-8. PubMed ID: 10582197 [TBL] [Abstract][Full Text] [Related]
51. Benefit-risk assessment of long-acting beta2-agonists in asthma. Jackson CM; Lipworth B Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036 [TBL] [Abstract][Full Text] [Related]
52. [Effect of slow-release theophylline on airway inflammation in bronchial asthma]. Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114 [TBL] [Abstract][Full Text] [Related]
53. Inhaled corticosteroids in children with persistent asthma: effects on growth. Zhang L; Prietsch SO; Ducharme FM Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972 [TBL] [Abstract][Full Text] [Related]
54. Antileukotriene drugs in childhood asthma: what is their place in therapy? Selvadurai H; Mellis C Paediatr Drugs; 2000; 2(5):367-72. PubMed ID: 11022798 [TBL] [Abstract][Full Text] [Related]
55. Drug treatment of asthma in the 1990s: achievements and new strategies. Tavakkoli A; Rees PJ Drugs; 1999 Jan; 57(1):1-8. PubMed ID: 9951947 [TBL] [Abstract][Full Text] [Related]
56. Pathology of asthma and its clinical implications. Beasley R; Burgess C; Crane J; Pearce N; Roche W J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):148-54. PubMed ID: 8335862 [TBL] [Abstract][Full Text] [Related]
57. Cromoglycate and nedocromil: influence on airway reactivity. Valletta EA; Boner AL Mediators Inflamm; 1994; 3(7):S15-9. PubMed ID: 18475597 [TBL] [Abstract][Full Text] [Related]
58. How does auranofin compare with methotrexate and cyclosporin as a corticosteroid-sparing agent in severe asthma? Bernstein IL; Bernstein DI; Bernstein JA BioDrugs; 1997 Sep; 8(3):205-15. PubMed ID: 18020511 [TBL] [Abstract][Full Text] [Related]
59. Classifying asthma severity and treatment determinants: national guidelines revisited. Khajotia R Malays Fam Physician; 2008; 3(3):131-6. PubMed ID: 25606137 [TBL] [Abstract][Full Text] [Related]
60. Doxofylline for Pediatric Asthma Steps 1-4. Pediatric Asthma: New Role for an Old Drug. Fierro V; Piscitelli AL; Battaglia E; Fiocchi A Front Pediatr; 2022; 10():772704. PubMed ID: 35813377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]